Accenture (ACN) is poised to report Q4 earnings on September 25th, with analysts projecting $2.97 EPS and $17.34 billion in sales, aligning with management's guidance that includes a 2% headwind from its federal business. Despite a history of exceeding estimates, ACN shares have declined 25% since the last coverage and 30% YTD, reflecting investor concerns over unimpressive overall growth and mid-single-digit declines in new bookings. While AI bookings grew 7% to $1.5 billion in Q3, the market awaits stronger evidence of this segment significantly offsetting broader weakness, leading to a maintained 'Hold' rating as the company trades at fair value given its current growth trajectory.
Ahead of its September 25th earnings report, Accenture (ACN) faces significant investor skepticism, reflected in its 30% year-to-date share price decline and stark underperformance against the S&P 500. Analyst consensus projects Q4 revenue of $17.34 billion and EPS of $2.97, aligning with the midpoint of management's guidance, which notably includes a 2% headwind from its federal business segment. While this represents a 5.5% year-over-year sales increase, the sequential decline and unimpressive overall growth rate are central to the negative sentiment. The core issue is a deterioration in forward-looking indicators; overall new bookings are declining in the mid-single digits, raising concerns about future revenue streams. Although the company's AI-related bookings have shown growth, rising from $1.4 billion in Q2 to $1.5 billion in Q3, this 7% increase is viewed as insufficient to offset broader weakness or materially impact the company's growth trajectory. The market is awaiting evidence of a significant acceleration in this segment to validate the AI growth narrative. With the stock now trading around its estimated fair value after the sell-off, there is no apparent valuation-driven catalyst for entry, reinforcing a cautious outlook pending a tangible improvement in growth fundamentals.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment